Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience

BACKGROUND: The long-term efficacy of infliximab (IFX) for patients with refractory ulcerative colitis (UC) is unclear. The aim of this study was to assess the long-term outcomes of IFX treatment in patients with refractory UC. METHODS: Thirty-three patients with refractory UC who received IFX treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Satoshi, Yoshino, Takuya, Matsuura, Minoru, Minami, Naoki, Toyonaga, Takahiko, Honzawa, Yusuke, Tsuji, Yoshihisa, Nakase, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012244/
https://www.ncbi.nlm.nih.gov/pubmed/24758588
http://dx.doi.org/10.1186/1471-230X-14-80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012244/
https://www.ncbi.nlm.nih.gov/pubmed/24758588
http://dx.doi.org/10.1186/1471-230X-14-80

Ejemplares similares